G261-0249 Screening compound: 2,2,6-trimethyl-N-[3-(4-methylpiperazin-1-yl)propyl]-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide

G261-0249 Screening compound: 2,2,6-trimethyl-N-[3-(4-methylpiperazin-1-yl)propyl]-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide
G261-0249 Screening compound: 2,2,6-trimethyl-N-[3-(4-methylpiperazin-1-yl)propyl]-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G261-0249
2,2,6-trimethyl-N-[3-(4-methylpiperazin-1-yl)propyl]-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G261-0249

Molecular Formula

C23H34N4O3S (C23 H34 N4 O3 S)

Compound Name

2,2,6-trimethyl-N-[3-(4-methylpiperazin-1-yl)propyl]-4-oxo-2,3,4,9-tetrahydro-1H-carbazole-7-sulfonamide

IUPAC name

226-trimethyl-N-[3-(4-methylpiperazin-1-yl)propyl]-4-oxo-2349-tetrahydro-1H-carbazole-7-sulfonamide

SMILES

CC(C)(Cc([nH]c1c2)c3c1cc(C)c2S(NCCCN1CCN(C)CC1)(=O)=O)CC3=O

InChI

InChI=1S/C23H34N4O3S/c1-16-12-17-18(25-19-14-23(2,3)15-20(28)22(17)19)13-21(16)31(29,30)24-6-5-7-27-10-8-26(4)9-11-27/h12-13,24-25H,5-11,14-15H2,1-4H3

InChI Key

ZUJSDPFJWYNHDU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14990356

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.61

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.060

Distribution Coefficient, logD

1.245

Water Solubility, LogSw

-2.67

Polar Surface Area

73.316

Acid Dissociation Constant (pKa)

11.43

Base Dissociation Constant (pKb)

8.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

60.90

G261-0249 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G261-0249 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G261-0249?
Check Price and Availability of G261-0249, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G261-0249 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G261-0249
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G261-0249
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G261-0249 available by request